首页> 外文OA文献 >A REVIEW: STATUS OF GENETIC MODULATED NONSMALL CELL LUNG CANCER TARGETS AND TREATMENT (CURRENT UPDATES IN DRUGS FOR NON-SMALL CELL LUNG CANCER TREATMENT)

【2h】

A REVIEW: STATUS OF GENETIC MODULATED NONSMALL CELL LUNG CANCER TARGETS AND TREATMENT (CURRENT UPDATES IN DRUGS FOR NON-SMALL CELL LUNG CANCER TREATMENT)

机译：综述：遗传调制的源性源细胞肺癌靶和治疗的状态（目前非小细胞肺癌治疗药物的最新情况）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Satyender Kumar; Priyank Purohit; Seema Dagar;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Pembrolizumab for the treatment of nonsmall cell lung cancer: Current status and future directions [J] . Qin Qin, Baosheng Li Journal of Cancer Research and Therapeutics . 2019,第4期

机译：派姆单抗治疗非小细胞肺癌的现状与发展方向
2. Current status of and future strategies for multimodality treatment of unresectable stage III nonsmall cell lung cancer [J] . HuberR.M., ReckM., ThomasM. The European respiratory journal : . 2013,第4期

机译：不可切除的III期非小细胞肺癌多模式治疗的现状和未来策略
3. Current status of and future strategies for multimodality treatment of unresectable stage III nonsmall cell lung cancer [J] . Martin Reck, Michael Thomas, Rudolf M. Huber The European respiratory journal : . 2013,第4期

机译：不可切除的III期非小细胞肺癌多模式治疗的现状和未来策略
4. Dosimetric and Clinical Benefits of Conformal Radiotherapy Plus Volumetric Modulated Arc Therapy in the Treatment of Non-small Cell Lung Cancer [C] . Xiance Jin, Congying Xie World Congress on Medical Physics and Biomedical Engineering . 2015

机译：保形放疗的剂量和临床益处加容积调节弧治疗非小细胞肺癌
5. The cost effectiveness of screening for early stage lung cancer and the testing and treatment of molecular subgroups among non-small cell lung cancer patients in the province of ontario, canada [D] . Thao, Mallory. 2014

机译：加拿大安大略省非小细胞肺癌患者早期肺癌筛查的成本效益及分子亚群的检测和治疗
6. Pretreatment neutrophil-to-lymphocyte ratio predicts treatment efficacy and prognosis of cytotoxic anticancer drugs molecular targeted drugs and immune checkpoint inhibitors in patients with advanced non-small cell lung cancer [O] . Masashi Ishihara, Ryosuke Ochiai, Terunobu Haruyama, 2021

机译：预处理中性粒细胞对淋巴细胞比率预测细胞毒性抗癌药物分子靶向药物和免疫检查点抑制剂的治疗疗效和预后抑制剂在先进的非小细胞肺癌患者中
7. Corrigendum to “Immune-checkpoint inhibition in first-line treatment of advanced non-small cell lung cancer patients: Current status and future approaches” Lung Cancer 106 (2017) 70–75 [O] . J. Remon, N. Pardo, A. Martinez-Martí, 2018

机译：“高级非小细胞肺癌患者的一线治疗中免疫检查点抑制的勘探：当前地位和未来方法”肺癌106（2017）70-75

A REVIEW: STATUS OF GENETIC MODULATED NONSMALL CELL LUNG CANCER TARGETS AND TREATMENT (CURRENT UPDATES IN DRUGS FOR NON-SMALL CELL LUNG CANCER TREATMENT)

著录项

引文网络

相似文献

相关主题

期刊订阅